DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Butts C, Socinski MA, Mitchell PL. et al
START trial team. Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.
Lancet Oncol 2014;
15 (01) 59-68
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.